Tyra Biosciences Price Target Raised to 33.00 at Oppenheimer

TYRA Stock  USD 16.00  0.28  1.78%   
About 65% of all Tyra Biosciences' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Tyra Biosciences suggests that some traders are interested. The current market sentiment, together with Tyra Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Tyra Biosciences stock news signals to limit their universe of possible portfolio assets.
  
Tyra Biosciences had its price objective raised by Oppenheimer from 25.00 to 33.00 in a research note released on Thursday morning, Benzinga reports. They currently have an outperform rating on the stock. TYRA has been the topic of a number of other research reports. HC Wainwright reiterated a buy rating and

Read at thelincolnianonline.com
news
  

Tyra Biosciences Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Tyra Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Tyra Biosciences Fundamental Analysis

We analyze Tyra Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tyra Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tyra Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Valuation

Current Valuation Comparative Analysis

Tyra Biosciences is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Tyra Biosciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tyra Biosciences stock to make a market-neutral strategy. Peer analysis of Tyra Biosciences could also be used in its relative valuation, which is a method of valuing Tyra Biosciences by comparing valuation metrics with similar companies.

Peers

Tyra Biosciences Related Equities

IPSCCentury Therapeutics   20.74   
0%
100.0%
RAPTRAPT Therapeutics   9.82   
0%
47.0%
CCCCC4 Therapeutics   8.59   
0%
41.0%
GLUEMonte Rosa   5.93   
0%
28.0%
ERASErasca   5.04   
0%
24.0%
MLYSMineralys Therapeutics,   4.71   
0%
22.0%
MOLNMolecular Partners   3.19   
0%
15.0%
CGEMCullinan Oncology   2.51   
0%
12.0%
XLOXilio Development   2.02   
0%
9.0%
STOKStoke Therapeutics   1.19   
0%
5.0%
PMVPPmv Pharmaceuticals   0.63   
0%
3.0%
HOWLWerewolf Therapeutics   0.51   
0%
2.0%
EWTXEdgewise Therapeutics   0.37   
0%
1.0%
CNTBConnect Biopharma   0.97   
4.0%
0%
IKNAIkena Oncology   1.17   
5.0%
0%
DSGNDesign Therapeutics   2.93   
14.0%
0%
PHVSPharvaris   7.49   
36.0%
0%

Complementary Tools for Tyra Stock analysis

When running Tyra Biosciences' price analysis, check to measure Tyra Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tyra Biosciences is operating at the current time. Most of Tyra Biosciences' value examination focuses on studying past and present price action to predict the probability of Tyra Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tyra Biosciences' price. Additionally, you may evaluate how the addition of Tyra Biosciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stocks Directory
Find actively traded stocks across global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital